Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Sex-specific role of microglia in Δ9-tetrahydrocannabinol-induced disruption of fear memory reconsolidation
    Published on 2026-05-09
    4 months ago
  • PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence
    Published on 2026-05-09
    4 months ago
  • Examining fronto-limbic brain and sleep mechanisms of antidepressant effects in cognitive-behavioral therapy for insomnia
    Published on 2026-05-07
    4 months ago
  • Computational phenotyping of effort-based decision-making in type-2 diabetes on and off semaglutide
    Published on 2026-05-06
    4 months ago
  • Traumatic stress recruits an excitatory orbitofrontal–amygdala pathway to drive maladaptive aggression
    Published on 2026-05-06
    4 months ago
  • Judith L. Rapoport, M.D. 1933–2026
    Published on 2026-05-05
    4 months ago
  • Maternal control during prenatal oxycodone exposure: differential effects of voluntary versus involuntary self-administration on offspring substance use vulnerability in rats
    Published on 2026-05-04
    4 months ago
« Previous 1 … 17 18 19 20 21 … 143 Next »
Journal of Psychopharmacology
  • An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice
    Published on 2026-01-06
    8 months ago
  • Every prescription is a prediction
    Published on 2026-01-06
    8 months ago
  • The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures
    Published on 2026-01-02
    8 months ago
  • The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences
    Published on 2025-12-31
    9 months ago
  • Potential use of propranolol in autism spectrum disorder: A narrative review
    Published on 2025-12-29
    9 months ago
  • Effects of ketamine enantiomers on morphine and THC subjective effects in rats
    Published on 2025-12-27
    9 months ago
  • The therapeutic readiness of probiotics in major depressive disorder: A systematic review of randomised controlled trials
    Published on 2025-12-27
    9 months ago
« Previous 1 … 17 18 19 20 21 … 154 Next »
European Neuropsychopharmacology
  • Activating β2-adrenergic receptor is a potential cross-disease therapeutic strategy for Alzheimer’s disease, obesity and type 2 diabetes
    Published on 2025-11-22
    10 months ago
  • Patterns, predictors and outcomes of trajectories for subjective quality of life in patients with early psychosis: 12-year follow-up of the randomized controlled trial on extended early intervention
    Published on 2025-11-22
    10 months ago
  • Persistent mortality gap in schizophrenia: current challenges and future directions
    Published on 2025-11-22
    10 months ago
  • Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis
    Published on 2025-11-08
    10 months ago
  • Chronic stress and brain kynurenine pathway: addressing unresolved issues with a meta-analytic approach of preclinical studies, translational implication for psychiatric disorders
    Published on 2025-11-07
    10 months ago
  • Commentary on the article “Efficacy of pharmacogenetic-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis”
    Published on 2025-10-28
    11 months ago
  • A call for more robust and interpretable models in predicting treatment-resistant depression
    Published on 2025-10-27
    11 months ago
« Previous 1 … 17 18 19 20 21 … 170 Next »

   Pharma Pub